Back to Isotope Catalog
R-11072

Quetiapine.half fumarate (d8)

Stable isotope standard for analytical research and method development.

Module Type
Stable Isotope Standards
Category
Drugs & TDM
CAS
1435938-24-1
Unlabeled CAS
1185247-12-4
PubChem CID
117065186
Molecular Formula
C46H38D16N6O8S2
Molecular Weight
899.2
AI Isotope Property & Application AnalysisShow

Isotope Summary

Labels
D16
Labeled atoms
16
Isotope positions
Partially confirmed in structure
Calculation reliability
Medium, some information should be confirmed

Mass & MS Parameters

Unlabeled exact mass
507.227921 Da
Labeled exact mass
898.444883 Da
Exact mass shift
391.216962 Da
Nominal mass shift
391
Ionm/zStatus
[M+H]+899.452159Theoretical
[M+Na]+921.434101Theoretical
[M+NH4]+916.478706Theoretical
[M-H]-897.437606Theoretical

Label Stability

Overall
Moderate risk
Calculation reliability
Medium, some information should be confirmed
  • Carbon-bound deuterium is evaluated by local chemical environment; isotope effects should still be checked experimentally.

Internal Standard Suitability

Rating
Medium
Chromatographic similarity
Possible isotope effect
Natural isotope overlap
Low
  • Exact mass separation is 391.216962 Da; MS channel separation should be verified in the final method.
  • A parent structure was available or matched for comparison.
  • Overall suitability: Medium.

Recommended Applications

LC-MS/MS Quantitative Internal Standard
Recommended

LC-MS/MS Quantitative Internal Standard is classified as Recommended based on isotope mapping, mass separation, and label-stability rules.

Isotope Dilution Mass Spectrometry
Recommended

Isotope Dilution Mass Spectrometry is classified as Recommended based on isotope mapping, mass separation, and label-stability rules.

GC-MS Internal Standard
Possible

GC-MS Internal Standard is classified as Possible based on isotope mapping, mass separation, and label-stability rules.

Clinical Mass Spectrometry
Possible

Clinical Mass Spectrometry is classified as Possible based on isotope mapping, mass separation, and label-stability rules.

Bioanalytical Method Development
Recommended

Bioanalytical Method Development is classified as Recommended based on isotope mapping, mass separation, and label-stability rules.

AI Interpretation

This analysis is based on isotope-aware structure data. The compound contains D16, with an exact mass shift of 391.216962 Da. Label stability is assessed as Moderate risk, and internal-standard suitability is Medium. These results support analytical method development and require experimental validation.

AI-assisted analytical guidance is intended for method-development support. Actual isotope stability, chromatographic behavior, fragmentation and MRM transitions should be experimentally validated.